Lineage Cell Therapeutics, Inc.
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2009 | $1.9M | $-3.5M | $-5.1M |
| FY2010 | $3.7M | $-9.9M | $-11.2M |
| FY2011 | $4.4M | $-18.7M | $-16.5M |
| FY2012 | $3.9M | $-25.0M | $-21.4M |
| FY2013 | $4.4M | $-56.0M | $-43.9M |
| FY2014 | $5.2M | $-50.7M | $-36.4M |
| FY2015 | $7.0M | $-65.8M | $-47.0M |
| FY2016 | $5.9M | $-59.0M | $33.6M |
| FY2017 | $3.5M | $-38.9M | $-20.0M |
| FY2018 | $5.0M | $-41.8M | $-46.0M |
| FY2019 | $3.5M | $-38.9M | $-11.7M |
| FY2020 | $1.8M | $-26.4M | $-20.6M |
| FY2021 | $4.3M | $-49.2M | $-43.0M |
| FY2022 | $14.7M | $-22.5M | $-26.3M |
| FY2023 | $8.9M | $-24.7M | $-21.5M |
| FY2024 | $9.5M | $-21.5M | $-18.6M |
| FY2025 | $14.6M | $-36.6M | $-63.5M |